Myricetin protects against doxorubicin-induced acute kidney injury in rats by mitigating oxidative damage and apoptotic response

IntroductionDoxorubicin (DOX) is a potent anti-neoplastic agent widely preferred in treating various tumors. However, DOX’s off-target toxicity in healthy tissues, such as nephrotoxicity, limits its clinical utilization. DOX generates oxidative stress and apoptosis in the kidneys, which stimulates c...

Full description

Saved in:
Bibliographic Details
Main Authors: Muhammed Talha Karadogan, Betul Cicek, Kagan Tolga Cinisli, Ali Sefa Mendil, Mustafa Ozkaraca, Furkan Yilmaz, Halis Suleyman
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1601628/full
Tags: Add Tag
No Tags, Be the first to tag this record!